U-Neuron Biomedical (ROCO:6973) EV-to-EBIT : -11.40 (As of May. 26, 2024)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, U-Neuron Biomedical's Enterprise Value is NT$966.88 Mil. U-Neuron Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-84.84 Mil. Therefore, U-Neuron Biomedical's EV-to-EBIT for today is -11.40.

The historical rank and industry rank for U-Neuron Biomedical's EV-to-EBIT or its related term are showing as below:

ROCO:6973' s EV-to-EBIT Range Over the Past 10 Years
Min: -17.22 Med: -9.72 Max: -8.17
Current: -11.4

During the past 4 years, the highest EV-to-EBIT of U-Neuron Biomedical was -8.17. The lowest was -17.22. And the median was -9.72.

ROCO:6973's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs ROCO:6973: -11.40

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. U-Neuron Biomedical's Enterprise Value for the quarter that ended in Dec. 2023 was NT$1,306.71 Mil. U-Neuron Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-84.84 Mil. U-Neuron Biomedical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -6.49%.

U-Neuron Biomedical EV-to-EBIT Historical Data

The historical data trend for U-Neuron Biomedical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical EV-to-EBIT Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-15.40

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	-	-	-	-	-15.40

Competitive Comparison of U-Neuron Biomedical's EV-to-EBIT

For the Biotechnology subindustry, U-Neuron Biomedical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's EV-to-EBIT falls into.

U-Neuron Biomedical EV-to-EBIT Calculation

U-Neuron Biomedical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	966.881	/	-84.836
	=	-11.40

U-Neuron Biomedical's current Enterprise Value is NT$966.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-84.84 Mil.

U-Neuron Biomedical (ROCO:6973) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

U-Neuron Biomedical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-84.836	/	1306.706
	=	-6.49 %

U-Neuron Biomedical's Enterprise Value for the quarter that ended in Dec. 2023 was NT$1,306.71 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-84.84 Mil.

U-Neuron Biomedical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines